Business Standard
Friday, Feb 17, 2012
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||||Economy & Policy||||| 
 Section Home | News Now | Today's Paper | Features & Analysis | Politics & Public Affairs | Q&A | Columnists | BS Says
Home > Economy & Policy Live Markets | Commodities
 
'Cap on drug prices to be counter-productive'
Asit Ranjan Mishra / New Delhi May 14, 2007
Union Chemicals Minister Ram Vilas Paswan’s proposal to expand the scope of price control on drugs through the draft National Pharmaceutical Policy, 2006, has met with serious objections from the Planning Commission.
 
The Department of Chemicals and Petrochemicals (DCP) has submitted the draft policy to the Cabinet. The policy proposes to bring all 354 essential medicines under price control, including the 74 bulk drugs and their formulations, as ordered by the Supreme Court.
 
Faced with strong protests from the pharma industry, the government set up a seven-member group of ministers under the chairmanship of Agriculture Minister Sharad Pawar to look into the various provisions of the draft. Planning Commission Deputy Chairman Montek Singh Ahluwalia is a member of the group.
 
The Plan panel has objected to the proposal saying the step could prove to be counter-productive by discouraging new investments in the pharma industry and limiting competition.
 
To counter the argument that Indian drugs were more expensive, the Plan panel said there was no evidence that the Indian pharmaceutical industry was overcharging. “Our medicine prices continue to be the lowest in the world,” an official source said.
 
The department has been saying that the policy has been formulated at the behest of a clear order from the Supreme Court.
 
The Planning Commission had advised that the opinion of the attorney-general be sought on the judgment.
 
However, the department had rebuffed the proposal saying the order of the apex court was so simple that it did not call for further legal opinion.
 
Despite this, the Plan panel reiterated its stance and said the draft policy in its present form would lead to proliferation of fraudulent practices and disappearance of essential medicines from the market.
 
The panel has suggested that the department place a separate detailed note before the Cabinet on the proposed extension of price control policy addressing the various issues raised by it.

 

'Cap on drug prices to be counter-productive'
Asit Ranjan Mishra / New Delhi May 14, 2007, 00:30 IST

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Wall Street opens flat as data offsets Moody's warning
- Thomas Cook India Q4 net jumps three times
- Govt plans to make 30% sourcing from MSEs mandatory
- Explain ways to cover govt loss on 3G roaming: TDSAT to telcos
- Magma Fincorp plans to start gold finance biz in H1 of FY13
  Read Business news in 
- Now property search gets more exciting than ever before!
- High Growth Business Opportunities in Africa - Register to explore
- Medium-sized businesses are the engines of a smarter planet.
- We live for our family. have you secured them?
- Office 365 for professionals and small businesses.
- Earn fuel worth Rs.2400 with Citi
- India's No. 1 Property Site. Click here to know more..
- Diseases earlier, Saving Costs, Extending Lives. Know More..
- Get 5% cashback on telephone bills with Citi
- Enjoy the journey as much as the destination. click to know more..
- Exim Bank Conclave on India - Africa Project Partnership. Know more..
- Be part of it The World's Largest Aircraft.
- Creating Wealth made simple the SIP way. Know more..
- Only Developer to give a guarantee on time space & rate.
- Buy Your Property with Our Triple Guarantee in India.
- Improve Patient Care & Experience. Click here to know more
- Win a Business Class Ticket to Europe..Know more..
-  Introduce a New Automotive Luxury Car.. know more
- Health is Wealth..... Insurance + Savings... Know More...
Sorry, comments to this story are closed
Latest Messages
SmartInvestor+ E-zine
  Pay Rs.747/- for 3 years and
  get a branded watch FREE

  Subscribe Now
Most Popular
Read
E-Mailed
Commented
   
- Asian stocks fall as Greek bailout delay dampens mood
- MCX IPO to make staff millionaires
- Marico: Stepping into unchartered territory
- Sonalde Desai: Sons of the soil
- Newsmaker: Salman Khurshid
 
 More  
New Ipad Application
 Business Standard's all new IPad  App
 Click here to download for free
  BS Specials  
    Full coverage of elections in Uttar Pradesh, Punjab, Uttarakhand, Manipur and Goa
  Hot Searches  
 
IRFC bond |  Antrix-Devas |  Rafale fighter |  Junglee |  IPL 5 |  Dhanlaxmi Bank |  Thomas Cook |  TCS |  Sarfaesi Act |  Vodafone |  Aakash tablet |  Sodexo |  Rupee |  Samsung Galaxy Note |  Kingfisher Airlines |  Silver |  Provident Fund |  income tax refund |  Anna Hazare |  iPhone |  Reliance Industries |  SEBI |  BSNL |  BSE |  NSE |  Mukesh Ambani |  Anil Ambani |  Infosys |  Pranab Mukherjee |  Sonia Gandhi |  Rahul Gandhi |  New Pension Scheme |  Reliance |  RBI |  GDP |  Gold |  Ratan Tata |  ICICI |  B-School |  Sensex |  Tax calculator |  Home Loan |  Personal Finance |  inflation |  oil prices |  Barack Obama |   
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
FOR HOT PRODUCTS
BS Bazaar.com
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us